{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:14:18Z","timestamp":1769922858832,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,1]]},"DOI":"10.7759\/cureus.37016","type":"journal-article","created":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T19:33:25Z","timestamp":1680377605000},"source":"Crossref","is-referenced-by-count":2,"title":["Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report"],"prefix":"10.7759","author":[{"given":"Abdulrahman","family":"Nasiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arwa","family":"Lami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alanoud","family":"Alhumaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afnan","family":"Madkhali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amnah","family":"Althaqib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norah","family":"Aljarwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem","family":"Alkharras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050595","article-title":"Blastic plasmacytoid dendritic cell neoplasm: state of the art and prospects","volume":"11","author":"Sapienza MR","year":"2019","unstructured":"Sapienza MR, Pileri A, Derenzini E, et al.. Blastic plasmacytoid dendritic cell neoplasm: state of the art and prospects. Cancers (Basel). 2019, 11:10.3390\/cancers11050595","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830470406","article-title":"High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma","volume":"47","author":"Adachi M","year":"1994","unstructured":"Adachi M, Maeda K, Takekawa M, Hinoda Y, Imai K, Sugiyama S, Yachi A. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol. 1994, 47:278-282. 10.1002\/ajh.2830470406","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14146","article-title":"Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches","volume":"174","author":"Pagano L","year":"2016","unstructured":"Pagano L, Valentini CG, Grammatico S, Pulsoni A. Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches. Br J Haematol. 2016, 174:188-202. 10.1111\/bjh.14146","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber DA","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et al.. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016, 127:2391-2405. 10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.06.002","article-title":"Blastic plasmacytoid dendritic cell neoplasm-current insights","volume":"19","author":"Venugopal S","year":"2019","unstructured":"Venugopal S, Zhou S, El Jamal SM, Lane AA, Mascarenhas J. Blastic plasmacytoid dendritic cell neoplasm-current insights. Clin Lymphoma Myeloma Leuk. 2019, 19:545-554. 10.1016\/j.clml.2019.06.002","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10489","article-title":"CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia","volume":"94","author":"Khoury JD","year":"2002","unstructured":"Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer. 2002, 94:2401-2408. 10.1002\/cncr.10489","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05639.x","article-title":"Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more?","volume":"149","author":"Kazakov DV","year":"2003","unstructured":"Kazakov DV, Mentzel T, Burg G, Dummer R, Kempf W. Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more?. Br J Dermatol. 2003, 149:869-876. 10.1046\/j.1365-2133.2003.05639.x","journal-title":"Br J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000647","article-title":"How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?","volume":"3","author":"Garnache-Ottou F","year":"2019","unstructured":"Garnache-Ottou F, Vidal C, Biichl\u00e9 S, et al.. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?. Blood Adv. 2019, 3:4238-4251. 10.1182\/bloodadvances.2019000647","journal-title":"Blood Adv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.07.033","article-title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: case series and literature review","volume":"36","author":"Rauh MJ","year":"2012","unstructured":"Rauh MJ, Rahman F, Good D, et al.. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: case series and literature review. Leuk Res. 2012, 36:81-86. 10.1016\/j.leukres.2011.07.033","journal-title":"Leuk Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.072645","article-title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study","volume":"98","author":"Pagano L","year":"2013","unstructured":"Pagano L, Valentini CG, Pulsoni A, et al.. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica. 2013, 98:239-246. 10.3324\/haematol.2012.072645","journal-title":"Haematologica"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.5.1556","article-title":"Clinical and biologic features of CD4(+)CD56(+) malignancies","volume":"99","author":"Feuillard J","year":"2002","unstructured":"Feuillard J, Jacob MC, Valensi F, et al.. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood. 2002, 99:1556-1563. 10.1182\/blood.v99.5.1556","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1309\/GJWNPD8HU5MAJ837","article-title":"Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review","volume":"123","author":"Petrella T","year":"2005","unstructured":"Petrella T, Bagot M, Willemze R, et al.. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005, 123:662-675. 10.1309\/GJWNPD8HU5MAJ837","journal-title":"Am J Clin Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1309\/W9Q5AGYDE5LANN39","article-title":"CD4+\/CD56+ hematodermic neoplasm (\"blastic natural killer cell lymphoma\"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon","volume":"128","author":"Pilichowska ME","year":"2007","unstructured":"Pilichowska ME, Fleming MD, Pinkus JL, Pinkus GS. CD4+\/CD56+ hematodermic neoplasm (\"blastic natural killer cell lymphoma\"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon. Am J Clin Pathol. 2007, 128:445-453. 10.1309\/W9Q5AGYDE5LANN39","journal-title":"Am J Clin Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000156","article-title":"Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients","volume":"38","author":"Julia F","year":"2014","unstructured":"Julia F, Dalle S, Duru G, et al.. Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients. Am J Surg Pathol. 2014, 38:673-680. 10.1097\/PAS.0000000000000156","journal-title":"Am J Surg Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.11.4154","article-title":"CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique","volume":"99","author":"Leroux D","year":"2002","unstructured":"Leroux D, Mugneret F, Callanan M, et al.. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique. Blood. 2002, 99:4154-4159. 10.1182\/blood.v99.11.4154","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.09.006","article-title":"Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group","volume":"34","author":"Tsagarakis NJ","year":"2010","unstructured":"Tsagarakis NJ, Kentrou NA, Papadimitriou KA, et al.. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group. Leuk Res. 2010, 34:438-446. 10.1016\/j.leukres.2009.09.006","journal-title":"Leuk Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.16","article-title":"Treatment of blastic plasmacytoid dendritic cell neoplasm","volume":"2016","author":"Sullivan JM","year":"2016","unstructured":"Sullivan JM, Rizzieri DA. Treatment of blastic plasmacytoid dendritic cell neoplasm. Hematology Am Soc Hematol Educ Program. 2016, 2016:16-23. 10.1182\/asheducation-2016.1.16","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.01.027","article-title":"Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation","volume":"19","author":"Kharfan-Dabaja MA","year":"2013","unstructured":"Kharfan-Dabaja MA, Lazarus HM, Nishihori T, Mahfouz RA, Hamadani M. Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2013, 19:1006-1012. 10.1016\/j.bbmt.2013.01.027","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2018.1512970","article-title":"The advances in therapy of blastic plasmacytoid dendritic cell neoplasm","volume":"27","author":"Kerr D 2nd","year":"2018","unstructured":"Kerr D 2nd, Sokol L. The advances in therapy of blastic plasmacytoid dendritic cell neoplasm. Expert Opin Investig Drugs. 2018, 27:733-739. 10.1080\/13543784.2018.1512970","journal-title":"Expert Opin Investig Drugs"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.12.012","article-title":"CD4+ CD56+ hematodermic\/plasmacytoid dendritic cell tumor with response to pralatrexate","volume":"58","author":"Leitenberger JJ","year":"2008","unstructured":"Leitenberger JJ, Berthelot CN, Polder KD, Pro B, McLaughlin P, Jones D, Duvic M. CD4+ CD56+ hematodermic\/plasmacytoid dendritic cell tumor with response to pralatrexate. J Am Acad Dermatol. 2008, 58:480-484. 10.1016\/j.jaad.2007.12.012","journal-title":"J Am Acad Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12294","article-title":"Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-azacytidine","volume":"93","author":"Laribi K","year":"2014","unstructured":"Laribi K, Denizon N, Ghnaya H, et al.. Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-azacytidine. Eur J Haematol. 2014, 93:81-85. 10.1111\/ejh.12294","journal-title":"Eur J Haematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2021.05.018","article-title":"Novel therapeutic approaches in blastic plasmacytoid dendritic cell neoplasm (BPDCN): era of targeted therapy","volume":"21","author":"Wilson NR","year":"2021","unstructured":"Wilson NR, Konopleva M, Khoury JD, Pemmaraju N. Novel therapeutic approaches in blastic plasmacytoid dendritic cell neoplasm (BPDCN): era of targeted therapy\r\n. Clin Lymphoma Myeloma Leuk. 2021, 21:734-740. 10.1016\/j.clml.2021.05.018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2020.01.006","article-title":"Immunotherapies targeting CD123 for blastic plasmacytoid dendritic cell neoplasm","volume":"34","author":"Xue T","year":"2020","unstructured":"Xue T, Budde LE. Immunotherapies targeting CD123 for blastic plasmacytoid dendritic cell neoplasm. Hematol Oncol Clin North Am. 2020, 34:575-587. 10.1016\/j.hoc.2020.01.006","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/145487-blastic-plasmacytoid-dendritic-cell-neoplasm-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:40Z","timestamp":1707508780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/145487-blastic-plasmacytoid-dendritic-cell-neoplasm-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.37016","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,1]]}}}